Versant Capital Management’s NantHealth, Inc NH Stock Holding History

Versant Capital Management’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8	Closed	–	–	1610
2017 Q2	$0	Buy	+8	New	+$443	﹤0.01%	1581

Other funds holding NH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Versant Capital Management's NH Position: Q3 2017 in Review

Versant Capital Management sold out of NantHealth, Inc (NH) in Q3 2017, closing a stake of 8 shares.

Versant Capital Management first reported a position in NH in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 47 funds tracked by Wall St. Rank hold NH as of Q3 2017.

Versant Capital Management reported no remaining NantHealth, Inc position as of Q3 2017 after selling out during the quarter.
Versant Capital Management sold 8 NantHealth, Inc shares in Q3 2017.
Versant Capital Management first reported a position in NantHealth, Inc in Q2 2017 and held it in 1 quarter.
Versant Capital Management's NantHealth, Inc position peaked at $0 in Q2 2017.
47 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2017.

Based on Versant Capital Management's 13F filing for Q3 2017, filed 23 Apr 2018.